Horne III et al., 1990 - Google Patents
Heparin‐like anticoagulant associated with systemic candidiasisHorne III et al., 1990
View PDF- Document ID
- 7162107852832063823
- Author
- Horne III M
- Chao E
- Wilson O
- Publication year
- Publication venue
- American journal of hematology
External Links
Snippet
A 15 year old girl with aplastic anemia developed a heparin‐like anticoagulant during the course of systemic candidiasis. This was initially detected in the laboratory by an elevation of the thrombin clotting time which corrected with toluidine blue but not by mixing with normal …
- 230000002429 anti-coagulation 0 title abstract description 46
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marder et al. | High molecular weight derivatives of human fibrinogen produced by plasmin: II. Mechanism of their anticoagulant activity | |
| Sie et al. | Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides | |
| Gugliotta et al. | Hypercoagulability during L‐asparaginase treatment: the effect of antithrombin III supplementation in vivo | |
| Yamagishi et al. | Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans | |
| Tamada et al. | Anticoagulant mechanism of sulfonated polyisoprenes | |
| Fischer et al. | Antithrombin III Alger: a new homozygous AT III variant | |
| Melo et al. | An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases | |
| Scully et al. | Anticoagulant and antiheparin activities of a pentosan polysulphate | |
| Mohri | Acquired von Willebrand disease in patients with polycythemia rubra vera | |
| Abildgaard | Antithrombin–early prophecies and present challenges | |
| Tanaka et al. | The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model | |
| Sherman et al. | Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A | |
| Lijnen et al. | Interaction of heparin with histidine-rich glycoprotein and with antithrombin III | |
| Walenga et al. | Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractions | |
| Zammit et al. | Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma | |
| Deguchi et al. | Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT) | |
| Sache et al. | Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin | |
| Hubbard et al. | Anticoagulant properties in vitro of heparan sulphates | |
| Horne III et al. | Heparin‐like anticoagulant associated with systemic candidiasis | |
| Pal et al. | Neutralization of heparin by histone and its subfractions | |
| Ding et al. | Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation | |
| De Munk et al. | Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin | |
| Horne III et al. | The effect of suramin on laboratory tests of coagulation | |
| Larrieu et al. | Biological effects of fibrinogen-fibrin degradation products | |
| Nowak-Göttl et al. | Asparaginase decreases clotting factors in vitro: a possible pitfall? |